达沙替尼与槲皮素衰老细胞清除联合促进大鼠肌腱-骨愈合:减轻年龄相关衰老
本研究在大鼠模型中探讨达沙替尼联合槲皮素(DQ)是否通过减少年龄相关衰老来增强肌腱-骨愈合。结果显示,老年大鼠肩袖止点p21表达高于年轻大鼠,DQ治疗显著降低衰老标志物表达、改善组织学评分和生物力学性能。
要点
- 老年大鼠肩袖止点p21表达显著高于年轻大鼠,肩袖撕裂手术进一步增加p21表达
- DQ组衰老标志物(p21、p16)及SASP因子(IL-6、IL-1β、MMP-3)基因表达较老年组显著降低
- DQ组组织学评分及失败载荷、刚度、应力均高于老年组
核心结论
- DQ治疗显著减轻老年大鼠肩袖止点的年龄相关细胞衰老,并增强肌腱-骨愈合。
研究设计与样本
- 对照实验室研究;第一阶段8只年轻成年(6月龄)和8只老年(24月龄)大鼠分为年轻假手术、年轻肩袖撕裂、老年假手术、老年肩袖撕裂4组,术后4周评估p21表达;第二阶段12只年轻成年和24只老年慢性肩袖撕裂大鼠行修复手术,分为年轻(溶媒)、老年(溶媒)、老年+DQ(DQ)3组,修复后12周评估基因表达、组织学和生物力学。
主要发现
- 老年大鼠p21表达显著高于年轻成年大鼠,肩袖撕裂手术进一步增强p21表达。
- 老年+DQ组衰老标志物(p21和p16)及衰老相关分泌表型因子(IL-6、IL-1β和MMP-3)基因表达较老年组显著降低。
- 老年+DQ组软骨生成基因(Acan和Col2a1)和肌腱生成基因(Col1a1、Tnmd和Scx)表达上调。
- 组织学分析显示老年+DQ组细胞衰老减少、肌腱-骨止点软骨和胶原发育改善,组织学评分高于老年组。
- 生物力学测试显示老年+DQ组失败载荷、刚度和应力均高于老年组。
临床怎么用
- 作者指出,DQ衰老细胞清除联合可能为老年患者肩袖撕裂的治疗提供有效的临床疗法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An age-dependent increase in cellular senescence has been identified in rotator cuff tears (RCTs). The senolytic combination of dasatinib and quercetin (DQ) has been demonstrated to alleviate musculoskeletal diseases by mitigating age-related senescence. However, the effects of DQ treatment on tendon-to-bone healing remain unknown. PURPOSE: To investigate whether DQ treatment can enhance tendon-to-bone healing by reducing age-related senescence in an aged rat model. STUDY DESIGN: Controlled laboratory study. METHODS: First, 8 young adult (6-month-old) and 8 aged (24-month-old) rats with sham or RCT surgery were categorized into 4 groups: young sham, young RCT, aged sham, and aged RCT. Four weeks after surgery, the p21 expression of the supraspinatus-humerus complexes was evaluated. Next, 12 young adult and 24 aged rats with chronic RCT underwent repair surgery and were categorized into 3 groups: young (administered vehicle treatment), aged (administered vehicle treatment), and aged + DQ (administered DQ). Twelve weeks after repair, the gene expression and histological and biomechanical properties of the supraspinatus-humerus complexes were evaluated. RESULTS: Aged rats demonstrated significantly higher p21 expression compared with young adult rats, and RCT surgery further enhanced p21 expression. The aged + DQ group demonstrated a significant decrease in the gene expression of senescence markers (p21 and p16) and senescence-associated secretory phenotype factors (IL-6, IL-1β, and MMP-3) compared with the aged group. Conversely, this group showed upregulation of both chondrogenic (Acan and Col2a1) and tenogenic (Col1a1, Tnmd, and Scx) genes. Histological analysis revealed that the aged + DQ group had decreased cellular senescence and improved cartilage and collagen development at the tendon-to-bone enthesis, with a higher histological score than the aged group. In addition, biomechanical testing indicated that the aged + DQ group had a higher failure load, stiffness, and stress than did the aged group. CONCLUSION: DQ treatment significantly alleviated age-related cellular senescence in the rotator cuff enthesis and enhanced tendon-to-bone healing in aged rats. CLINICAL RELEVANCE: The senolytic combination of DQ could potentially provide effective clinical therapy for the treatment of RCT in older patients.
引用
- Cai Z, Wang H, Hu J, et al. Senolytic Combination of Dasatinib and Quercetin Promotes Tendon-to-Bone Healing by Mitigating Age-Related Senescence in Rats. Am J Sports Med. 2025. PMID: 41105426. doi:10.1177/03635465251381763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。